These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 19152967)

  • 1. A hypoallergenic variant of Der p 1 as a candidate for mite allergy vaccines.
    Walgraffe D; Mattéotti C; El Bakkoury M; Garcia L; Marchand C; Bullens D; Vandenbranden M; Jacquet A
    J Allergy Clin Immunol; 2009 May; 123(5):1150-6. PubMed ID: 19152967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination with the recombinant allergen ProDer p 1 complexed with the cationic lipid DiC14-amidine prevents allergic responses to house dust mite.
    Jacquet A; Vanderschrick JF; Vandenbranden M; Elouahabi A; Magi M; Garcia L; Ruysschaert JM
    Mol Ther; 2005 Jun; 11(6):960-8. PubMed ID: 15922967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heat denaturation affects the ProDer p 1 IgE reactivity and downregulates the development of the specific allergic response.
    Magi M; Garcia L; Vandenbranden M; Palmantier R; Jacquet A
    J Allergy Clin Immunol; 2004 Sep; 114(3):545-52. PubMed ID: 15356555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering of major house dust mite allergens Der p 1 and Der p 2 for allergen-specific immunotherapy.
    Asturias JA; Ibarrola I; Arilla MC; Vidal C; Ferrer A; Gamboa PM; Viñuela JE; Sanz ML; Andreu C; Martínez A
    Clin Exp Allergy; 2009 Jul; 39(7):1088-98. PubMed ID: 19400901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of folded recombinant Der p 5, a potential diagnostic marker allergen for house dust mite allergy.
    Weghofer M; Grote M; Dall'Antonia Y; Fernández-Caldas E; Krauth MT; van Hage M; Horak F; Thomas WR; Valent P; Keller W; Valenta R; Vrtala S
    Int Arch Allergy Immunol; 2008; 147(2):101-9. PubMed ID: 18520154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of recombinant stable house dust mite allergen Der p 3 molecules for component-resolved diagnosis and specific immunotherapy.
    Bouaziz A; Walgraffe D; Bouillot C; Herman J; Foguenne J; Gothot A; Louis R; Hentges F; Jacquet A; Mailleux AC; Chevigné A; Galleni M; Adam E; Dumez ME
    Clin Exp Allergy; 2015 Apr; 45(4):823-34. PubMed ID: 25406386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of the in vivo allergenicity of Der p 2, the major house-dust mite allergen, by genetic engineering.
    Chen KW; Fuchs G; Sonneck K; Gieras A; Swoboda I; Douladiris N; Linhart B; Jankovic M; Pavkov T; Keller W; Papadopoulos NG; Valent P; Valenta R; Vrtala S
    Mol Immunol; 2008 May; 45(9):2486-98. PubMed ID: 18295887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of immunoglobulin E synthesis and airway eosinophilia by vaccination with plasmid DNA encoding ProDer p 1.
    Jacquet A; Magi M; Haumont M; Jurado M; Garcia L; Bollen A
    Clin Exp Allergy; 2003 Feb; 33(2):218-25. PubMed ID: 12580915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probiotic Escherichia coli Nissle 1917 activates DC and prevents house dust mite allergy through a TLR4-dependent pathway.
    Adam E; Delbrassine L; Bouillot C; Reynders V; Mailleux AC; Muraille E; Jacquet A
    Eur J Immunol; 2010 Jul; 40(7):1995-2005. PubMed ID: 20432233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production and immunogenicity of hypoallergenic codon-optimized DNA vaccine encoding mature Der p 1 allergen.
    Pulsawat P; Piboonpocanun S; Sirivichayakul S; Buranapraditkun S; Jacquet A; Shimada M; Okuda K; Ruxrungtham K
    J Investig Allergol Clin Immunol; 2010; 20(7):582-90. PubMed ID: 21313999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo and in vitro immunomodulation of Der p 1 allergen-specific response by Lactobacillus plantarum bacteria.
    Hisbergues M; Magi M; Rigaux P; Steuve J; Garcia L; Goudercourt D; Pot B; Pestel J; Jacquet A
    Clin Exp Allergy; 2007 Sep; 37(9):1286-95. PubMed ID: 17845408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant fusion proteins assembling Der p 1 and Der p 2 allergens from Dermatophagoides pteronyssinus.
    Bussières L; Bordas-Le Floch V; Bulder I; Chabre H; Nony E; Lautrette A; Berrouet C; Nguefeu Y; Horiot S; Baron-Bodo V; Van Overtvelt L; De Conti AM; Schlegel A; Maguet N; Mouz N; Lemoine P; Batard T; Moingeon P
    Int Arch Allergy Immunol; 2010; 153(2):141-51. PubMed ID: 20407270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA vaccine encoding Der p 2 allergen generates immunologic protection in recombinant Der p 2 allergen-induced allergic airway inflammation mice model.
    Li GP; Liu ZG; Qiu J; Ran PX; Zhong NS
    Chin Med J (Engl); 2005 Apr; 118(7):534-40. PubMed ID: 15820083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoallergenic Der p 1/Der p 2 combination vaccines for immunotherapy of house dust mite allergy.
    Chen KW; Blatt K; Thomas WR; Swoboda I; Valent P; Valenta R; Vrtala S
    J Allergy Clin Immunol; 2012 Aug; 130(2):435-43.e4. PubMed ID: 22789398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a hypoallergenic recombinant Bet v 1 variant as a candidate for allergen-specific immunotherapy.
    Kahlert H; Suck R; Weber B; Nandy A; Wald M; Keller W; Cromwell O; Fiebig H
    Int Arch Allergy Immunol; 2008; 145(3):193-206. PubMed ID: 17912007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of therapeutic sublingual vaccines in a murine model of chronic house dust mite allergic airway inflammation.
    Tourdot S; Airouche S; Berjont N; Da Silveira A; Mascarell L; Jacquet A; Caplier L; Langelot M; Baron-Bodo V; Moingeon P
    Clin Exp Allergy; 2011 Dec; 41(12):1784-92. PubMed ID: 22092967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineered recombinant ovomucoid third domain can modulate allergenic response in Balb/c mice model.
    Rupa P; Mine Y
    Biochem Biophys Res Commun; 2006 Apr; 342(3):710-7. PubMed ID: 16494843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of purified Dermatophagoides pteronyssinus allergens and extract by two-dimensional immunoblotting and quantitative immunoglobulin E inhibitions.
    Weghofer M; Thomas WR; Pittner G; Horak F; Valenta R; Vrtala S
    Clin Exp Allergy; 2005 Oct; 35(10):1384-91. PubMed ID: 16238800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion of Der p 23, a new major house dust mite allergen, into a hypoallergenic vaccine.
    Banerjee S; Weber M; Blatt K; Swoboda I; Focke-Tejkl M; Valent P; Valenta R; Vrtala S
    J Immunol; 2014 May; 192(10):4867-75. PubMed ID: 24733847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing allergenicity by altering allergen fold: a mosaic protein of Phl p 1 for allergy vaccination.
    Ball T; Linhart B; Sonneck K; Blatt K; Herrmann H; Valent P; Stoecklinger A; Lupinek C; Thalhamer J; Fedorov AA; Almo SC; Valenta R
    Allergy; 2009 Apr; 64(4):569-80. PubMed ID: 19243361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.